Introduction {#s1}
============

Osteoporosis is a silently progressive disease characterized by excessive bone loss and structural deterioration until it clinically presents as bone fragility and fracture. While mostly afflicting post-menopausal women and the elderly ([@bib37]), it also manifests in adolescents and adults as a result of endocrine and metabolic abnormalities or medications ([@bib32]). Osteoporosis is largely or partially caused by diminished bone forming activity and often accompanied by increases in marrow adiposity. Therefore, understanding the nature of bone marrow mesenchymal stem cells (MSCs) and their differentiation routes into osteoblasts and adipocytes has always been the center of bone research. However, in contrast to the wealth of knowledge regarding hematopoiesis from hematopoietic stem cells (HSCs) ([@bib40]), our in vivo knowledge of MSCs and their descendants are largely incomplete, which has greatly limited advances in treating clinical disorders of bone loss.

It is well-accepted that bone marrow mesenchymal progenitors are heterogeneous, including MSCs and their descendants at various differentiation stages before they reach the terminal states as osteoblasts, osteocytes, and adipocytes. Our current knowledge of those progenitors is mostly dependent on cell expansion in culture for CFU-F, multi-lineage differentiation, and transplantation assays. However, in vitro culture does not necessarily replicate in vivo cell behavior after depleting their environmental cues. Another common approach is lineage tracing that uses a specific promoter-driven *Cre* or *CreER* system to label a portion of mesenchymal lineage cells. However, it generally does not provide information about the specific stage(s) of mesenchymal progenitors that cells start to be labeled. The recently available large-scale single cell RNA-sequencing (scRNA-seq), which is capable of identifying and interrogating rare cell populations and deducting the course of differentiation ([@bib63]), finally provides an unbiased tool to investigate bone marrow mesenchymal cells in vivo.

Several recent reports applied this technique on mouse bone marrow mesenchymal cells. Based on previous studies that leptin receptor (Lepr) marks adult bone marrow MSCs ([@bib65]) and Lepr^+^ cells serve as niche for hematopoietic progenitors ([@bib10]), one study used *Lepr-Cre* to label mesenchymal stromal cells and *Col1a-Cre* to label osteoblasts for analyzing HSC niches ([@bib55]). Another one utilized *Cxcl12-CreER* to label bone marrow stromal cells ([@bib29]). The others depleted hematopoietic cells from bone marrow and analyze the remaining bone marrow cells ([@bib2]; [@bib3]; [@bib60]). Interestingly, all those studies identified a large cell cluster expressing many adipocyte markers and in some studies this cluster was annotated as MSC. For our study, we used a different approach by taking advantage of a *Col2-Cre Rosa26 \<lsl-tdTomato\>* (Col2:Td) mouse model that we and others previously reported to label bone marrow mesenchymal lineage cells ([@bib39]; [@bib8]). Since in this model Td labels every osteocyte and every bone marrow adipocyte in vivo and all CFU-F-forming cells, we reason that all bone marrow mesenchymal lineage cells, including all mesenchymal progenitors, are included within the Td^+^ population. By applying large scale scRNA-seq on this population derived from various age groups, we identified an in vivo the most primitive progenitor population different from previous reports and delineated the in vivo evolvement of early mesenchymal progenitors into mature osteogenic and adipogenic cells through hierarchical differentiation paths. Among newly identified mesenchymal subpopulations, a new type of adipose lineage cells is subsequently validated and investigated for their critical actions in regulating bone marrow vasculature and bone homeostasis.

Results {#s2}
=======

Single cell transcriptomic profiling of bone marrow mesenchymal lineage cells {#s2-1}
-----------------------------------------------------------------------------

Consistent with our previous report ([@bib8]), Td labeled the following cells in the long bone of 1-month-old Col2:Td mice: all chondrocytes (1052 out of 1052 chondrocytes counted, n = 4 mice, 100%) in the growth plate, osteoblasts and all osteocytes (3600 out of 3600 osteocytes counted, n = 4 mice, 100%) in trabecular and cortical bone, all CD45^-^ stromal cells (2050 out of 2050 cells with stromal morphology counted, n = 4 mice, 100%), all Perilipin^+^ adipocytes (5 out of 5 adipocytes counted, n = 4 mice, 100%), and many pericytes throughout the bone marrow from metaphysis to diaphysis ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). We previously developed an enzymatic digestion method to release bone marrow cells trapped within the trabecular bone (endosteal bone marrow) and demonstrated that they contain a higher frequency of mesenchymal progenitors than central bone marrow flushed from the diaphysis of long bones ([@bib49]). This enzymatic digestion method collects osteoblasts as well and thus, is better than conventional flushing method by providing a definite cluster of mature cells for single cell analysis. Due to its small quantity, Td^+^ peak among endosteal bone marrow cells was sometimes distinguishable (1.2 ± 0.1%) but often not. Nevertheless, fractioning all cells into the top 1%, 1--2%, and \>2% cells based on the Td signal ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}) revealed that the top 1% group contains all the CFU-F forming cells ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}) and almost all CFU-F colonies (98.7%) are Td^+^ ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). Since osteoblasts are also Td^+^, these data suggested that the top 1% cells include all bone marrow mesenchymal progenitors as well as osteoblasts.

![Clustering of bone marrow mesenchymal lineage cells by single cell transcriptomics reveals the in vivo identity of novel mesenchymal subpopulations.\
(**A**) Fluorescent image of distal femur of 1-month-old Col2:Td mice. (**B**) The tSNE plot of 7585 Td^+^ mesenchymal lineage cells isolated from endosteal bone marrow of 1--1.5 month-old Col2:Td mice (n = 5 mice). Cell numbers are listed in parenthesis next to cluster names. OB: osteoblast; Ocy: osteocyte; LCP: lineage committed progenitor; AD: adipocyte; CH: chondrocyte. (**C**) Violin plots of marker gene expression for EMPs, LMPs, osteoblast/osteocyte, adipocyte, and chondrocyte clusters. (**D**) Monocle trajectory plot of bone marrow mesenchymal lineage cells. (**E**) Slingshot trajectory plot of bone marrow mesenchymal lineage cells. In D and E, cells are labeled according to their Seurat clusters. (**F**) The percentage of proliferative cells (S/G2/M phase) among each cluster was quantified. (**G**) Hierarchy clustering and heatmap of mesenchymal lineage clusters. Color bar on the top indicates the gene expression level. Each cluster contains two batches (top and bottom) of samples.](elife-54695-fig1){#fig1}

Using 10x Genomics approach, we sequenced the top 1% Td^+^ endosteal bone marrow cells from 1- to 1.5-mo-old Col2:Td mice. We profiled 13,759 cells with a median of 2686 genes/cell and a median of 12215 UMIs/cell ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). Unsupervised clustering of the gene expression profiles using Seurat identified 22 groups, including 9 groups of mesenchymal lineage cells and 11 groups of hematopoietic cells, 1 group of endothelial cells, and 1 group of mural cells ([Figure 1---figure supplement 2B-D](#fig1s2){ref-type="fig"}). For reasons unclear at present, we observed a large number of non-mesenchymal lineage cells, which is confirmed by detectable *Td* and *Col2a1* expression in those cells ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). tSNE ([Figure 1B](#fig1){ref-type="fig"}) and UMAP ([Figure 1---figure supplement 4A](#fig1s4){ref-type="fig"}) analyses of 7585 mesenchymal lineage cells yielded the same cell cluster pattern containing 9 subpopulations. Cells from two batches of experiments were present at a roughly similar proportion in each subpopulation ([Figure 1---figure supplement 4B, C](#fig1s4){ref-type="fig"}). Examination of lineage-specific markers identified clusters with gene signatures of osteoblast (cluster 4), osteocyte (cluster 5), adipocyte (cluster 7), and chondrocyte (cluster 8 and 9, [Figure 1C](#fig1){ref-type="fig"}). Chondrocyte clusters, while unexpected, likely represent growth plate chondrocytes released from bone fragments during enzymatic digestion after we cut off epiphyses at the growth plate site. Since chondrocytes originate from the resting zone progenitors but not bone marrow MSCs ([@bib34]), they were excluded from subsequent analysis.

Interestingly, pseudotemporal cell trajectory analysis using Monocle ([@bib57]) placed cells in cluster 1 at one end of pseudotime trajectory and osteocytes (cluster 5) and adipocytes (cluster 7), two terminally differentiated cell types, at the opposite, divergent ends ([Figure 1D](#fig1){ref-type="fig"}). Slingshot ([@bib51]), another method for inferring cell lineages and pseudotimes, generated a similar trajectory pattern ([Figure 1E](#fig1){ref-type="fig"}). These data suggested that cluster 1 cells are the ancestor of other mesenchymal cells in the dataset and that they bi-differentiate into osteogenic and adipogenic lineage cells. Indeed, cluster 1 expressed several common stem cell markers, such as stem cell antigen 1 (Sca1), Cd34, and Thy1 ([Figure 1C](#fig1){ref-type="fig"}). Hence, we named cluster 1 as early mesenchymal progenitors (EMPs), the most primitive cells in the sequencing dataset. Since these data are derived from *Col2-Cre* labeled cells, we cannot exclude the possibility that the bone marrow contains even more primitive Td^-^ cells that give rise to cluster 1 cells. That said, the labelling of essentially all CFU-F forming cells in Col2:Td bone marrow by Td, makes that possibility unlikely. Compared to cluster 1, clusters 2, 3, and 4 (osteoblast) expressed gradually increased levels of osteogenic genes, such as *Sp7, Runx2, Col1a1, Ibsp*, and *Bglap2*. Since clusters 2 and 3 are sequentially located after cluster 1 and before the branch point in pseudotime trajectory, we named cluster 2 as intermediate mesenchymal progenitors (IMPs) and cluster 3 as late mesenchymal progenitors (LMPs). Cells in cluster 6 were distributed around the branch point, indicating that they are lineage committed progenitors (LCPs).

Computational cell cycle analysis was performed to understand the proliferative status of each cluster ([Figure 1F](#fig1){ref-type="fig"}). As a positive control, chondrocyte cluster 9, corresponding to proliferative and prehypertrophic growth plate chondrocytes, had the highest proliferative status. It appeared that within bone marrow mesenchymal lineage cells, EMPs are less proliferative than IMPs; LMPs, LCPs, and osteoblasts are the most proliferative; adipocytes and osteocytes are non-proliferative. These results further support our cluster annotation. Hierarchy analysis showed distinct gene expression signatures in each cluster ([Figure 1G](#fig1){ref-type="fig"}).

During the past decade, many proteins have been proposed as mesenchymal progenitor markers based on lineage tracing and in vitro culture data, such as Lepr ([@bib65]), myxovirus resistance-1 (Mx1) ([@bib42]), glioma-associated oncogene homolog 1 (Gli1) ([@bib48]), paired related homeobox 1 (Prxx1) ([@bib26]), gremlin (Grem1) ([@bib61]), platelet derived growth factor receptor alpha (Pdgfrα)/Sca1 (PαS) ([@bib35]), Nestin ([@bib30]), Osterix ([@bib33]), c-x-c motif chemokine 12 (Cxcl12) ([@bib38]), integrinαV/OX-2 membrane glycoprotein (Cd200) ([@bib6]), and early B cell factor 3 (Ebf3) ([@bib46]). However, our data suggested that among them, only Sca1 preferentially marks cluster 1. *Pdgfra, Itgav, Gli1,* and *Prrx1* are broadly expressed across all mesenchymal lineage cells; *Sp7 (Osterix)* and *Cd200* are expressed at a higher level in LMPs and LCPs than in EMP; *Grem1, Lepr, Cxcl12* and *Ebf3* are highly expressed in adipocytes but also have expression in other mesenchymal cells ([Figure 1---figure supplement 5A](#fig1s5){ref-type="fig"}); *Nestin* and *Mx1* are mainly expressed in endothelial/mural cells and hematopoietic cells, respectively ([Figure 1---figure supplement 5B](#fig1s5){ref-type="fig"}). Their expression patterns were further confirmed by UMAP ([Figure 1---figure supplement 5C, D](#fig1s5){ref-type="fig"}). Hence, the in vivo EMPs we computationally identified here are similar to the previously proposed PαS cells but different from other proposed MSCs. PαS cells have been shown to display mesenchymal progenitor properties in culture and after transplantation ([@bib35]).

The osteogenic and adipogenic lineage commitment of bone marrow mesenchymal progenitors {#s2-2}
---------------------------------------------------------------------------------------

Positioning individual cells along a linear pseudotimeline with EMPs as the root revealed transcription factors (TFs) differentially expressed after the branch point of osteogenic and adipogenic lineages ([Figure 2A](#fig2){ref-type="fig"}). Consistent with its longer differentiation pseudotime, adipogenic differentiation required many more unique TFs than osteogenic differentiation, including master regulators *Pparg* and *Cebpa*, several known TFs related to adipogenesis, such as *Klf2, Ebf1,* and *Ebf2* ([@bib23]), as well as many novel ones. Surprisingly, this analysis only revealed master osteogenic regulator *Sp7* but not *Runx2*. Indeed, the expression of *Runx2* started from IMPs and stayed constant during osteogenic differentiation ([Figure 1C](#fig1){ref-type="fig"}). Our observation that adipogenic differentiation is accompanied with more changes in TFs than osteogenic differentiation is consistent with a recent analysis of in vitro adipogenic and osteogenic differentiation of human MSC-TERT4 cells ([@bib44]).

![The bifurcated osteo- and adipo-lineage differentiation routes of in vivo bone marrow mesenchymal progenitors.\
(**A**) Pseudotemporal depiction of differentially expressed transcription factors (TFs) starting from branching point (dashed lines) toward osteo- (right) and adipo- (left) lineage differentiation. Group I and II contain TFs that are highly up-regulated during osteogenic and adipogenic differentiation routes, respectively. Color bar indicates the gene expression level. (**B**) Differentially regulated (up-regulated and down-regulated) genes during osteogenic and adipogenic differentiation are counted. (**C**) GO term and KEGG pathway analyses of genes up-regulated and down-regulated during osteogenic and adipogenic differentiation. Note that some pathways, such as osteoblast differentiation, are identified by both up-regulated and down-regulated genes. This is due to the fact that a set of genes in a pathway are up-regulated while another set of genes in the same pathway are down-regulated. (**D**) Expression of *Dmp1* goes from the progenitor state and bifurcating into osteogenic or adipogenic branches with respect to pseudotime coordinates. (**E**) The tSNE plot predicts *Dmp1* expression in osteoblasts, osteocytes, and a portion of LCPs. (**F**) In 3-month-old Dmp1:Td mice, Td labels osteoblasts, osteocytes (**a**), and only a few adipocytes (b, arrows). (**G**) Expression of *αSMA* (*Acta2*) goes from the progenitor state and bifurcating into osteogenic or adipogenic branches with respect to pseudotime coordinates. (**H**) The tSNE plot predicts *αSMA* expression in LMPs. (**I**) In 4-month-old Acta2ER:Td mice with Tamoxifen injections at 1 month of age, Td labels osteoblasts, osteocytes (**a**) and many adipocytes (b, arrows).](elife-54695-fig2){#fig2}

Analyzing differentiated expressed genes (DEGs) revealed that up-regulated genes are distinct for each lineage whereas there is considerable overlap between down-regulated genes ([Figure 2B](#fig2){ref-type="fig"}). GO term and KEGG analyses of DEGs revealed unique and common features of osteogenic and adipogenic differentiation processes ([Figure 2C](#fig2){ref-type="fig"}). Some pathways, such as PI3K-Akt, TGFβ, and FoxO signaling pathways, were altered in both lineages, implying their general role in regulating mesenchymal differentiation. Accompanied by downregulation of translation, ribosomal genes were down-regulated in both osteocytes and adipocytes, confirming that they are terminally differentiated, highly specialized cells. The unique features of osteogenic differentiation include extracellular matrix (ECM) organization, ECM-receptor interaction, axon guidance, actin cytoskeleton, and biomineral tissue development, all of which reflect their bone building function. Interestingly, the unique features of adipogenic differentiation include cytokine-cytokine receptor interaction, immune system process, circadian rhythm, osteoclast differentiation, TNF, HIF-1, chemokines signaling pathways, among others. Considering that adipocytes reside in a hematopoietic environment with affluent blood vessels, these features suggest an important regulatory role of adipocytes on its marrow environment.

To validate the lineage differentiation routes predicted by our Seurat and Monocle data, we chose two genes, *Dmp1* and *Acta2 (αSMA*), for further investigation. DMP1 was previously reported as an osteocyte marker ([@bib27]). Our sequencing analysis revealed that its expression is turned on in LCPs mostly in osteogenic differentiation route ([Figure 2D,E](#fig2){ref-type="fig"}). In 3-month-old *Dmp1-Cre Rosa26 \<lsl-tdTomato\>* (Dmp1:Td) mice, Td labeled almost all osteoblasts and osteocytes, some stromal cells and a few Perilipin^+^ adipocytes (6 out of 92 adipocytes counted, n = 3 mice, 6.1%, [Figure 2F](#fig2){ref-type="fig"}), which is similar to a previously reported Dmp1-Cre targeting pattern ([@bib24]). αSMA was previously reported as an osteoprogenitor marker ([@bib19]). We found that it is a marker for the LMP cluster ([Figure 2G,H](#fig2){ref-type="fig"}). In *Acta2-CreER Rosa26 \<lsl-tdTomato\>* (Acta2ER:Td) mice at 3 months after Tamoxifen injections, Td labeled many osteoblasts, osteocytes (185 out of 256 osteocytes counted, n = 3 mice, 68.2%), and bone marrow Perilipin^+^ adipocytes (42 out of 124 adipocytes counted, n = 3 mice, 33.7%, [Figure 2I](#fig2){ref-type="fig"}), confirming that αSMA labels mesenchymal progenitors before bifurcated differentiation.

Age-dependent changes in bone marrow mesenchymal subpopulations {#s2-3}
---------------------------------------------------------------

Mouse bone marrow mesenchymal progenitor pool shrinks drastically over time. Indeed, CFU-F frequency of endosteal bone marrow harvested from 16-month-old *Col2:Td* mice decreased by 73% compared to that from 1-month-old mice ([Figure 3A](#fig3){ref-type="fig"}). Similar to adolescent mice, almost all CFU-F colonies from adult and aging mice were Td^+^ ([Figure 3A](#fig3){ref-type="fig"}) and top 1% Td^+^ cells sorted from endosteal bone marrow contained almost all CFU-Fs (100% Td^+^) in unsorted cells ([Figure 3---figure supplement 1A, B](#fig3s1){ref-type="fig"}). These data support the use of a similar scRNA-seq approach on adult and aging bone marrow mesenchymal lineage cells.

After quality control, we obtained 4502 cells with 19 clusters in a 3 month dataset and 8823 cells with 16 clusters in a 16 month dataset ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). Among them, 2510 (2040 genes/cell and 7243 UMIs/cell) and 7354 (2671 genes/cell and 9660 UMIs/cell) were mesenchymal lineage cells in 3 and 16 month dataset, respectively. Unsupervised clustering of cells in both datasets using tSNE and UMAP yielded similar clustering patterns ([Figure 3B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}) and cluster markers ([Figure 3C](#fig3){ref-type="fig"}) as 1 month dataset. Notably, IMP cluster was not detected in 16 month dataset. After removing chondrocytes, pseudotime trajectories using either Monocle or Slingshot again put EMPs at one end and osteocytes and adipocytes at the other two ends ([Figure 3D](#fig3){ref-type="fig"}).

Merging all age datasets generated 6 clusters: EMP, LMP, osteoblast, osteocyte, LCP, and adipocyte ([Figure 3E](#fig3){ref-type="fig"}). It is conceivable that the mesenchymal progenitor pool with bi-lineage differentiation ability was drastically shrunk in the aging sample while the adipocyte population was greatly expanded ([Figure 3F-G](#fig3){ref-type="fig"}), which is consistent with our CFU-F results. Pseudotime trajectory analyses again revealed a similar Y shape curve as 1 month dataset ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). Interestingly, while EMP and LMPs in 1 and 3 month datasets were more centered at the starting point of pseudotime, those cells in 16 month dataset shifted toward differentiated status, particularly the adipocyte end ([Figure 3---figure supplement 2B, C](#fig3s2){ref-type="fig"}). We further examined the expression pattern of adipocyte markers in each cell cluster among different age groups ([Figure 3---figure supplement 2D](#fig3s2){ref-type="fig"}). Some of them, such as *Cebpa* and *Lpl,* were expressed at higher levels in most mesenchymal subpopulations, particularly EMP and LMP, in 16 month dataset comparing to 1 and 3 month datasets, suggesting an adipocytic drift during aging. Lepr was previously described as a marker labeling adult MSCs but not young MSCs ([@bib65]). Here we observed that Lepr expression is much higher in 16 month EMPs than in 1 month EMPs, likely providing an explanation for why *Lepr-Cre* labels adult MSCs but not young MSCs in mouse bone marrow ([@bib65]).

![Large scale scRNA-seq analyses of bone marrow mesenchymal lineage cells from 3- and 16-month-old Col2:Td mice confirm the same in vivo mesenchymal subpopulations as 1-month-old mice.\
(**A**) CFU-F assays of endosteal bone marrow cells from 1-, 3-, and 16-month-old Col2:Td mice. n = 3 mice/group. Td^+^ and Td^-^ CFU-F colonies are quantified. (**B**) The tSNE plots of Td^+^ mesenchymal lineage cells isolated from endosteal bone marrow of 3- and 16-month-old Col2:Td mice (n = 3 mice/group). Cell numbers are listed in parenthesis next to cluster names. OB: osteoblast; Ocy: osteocyte; LCP: lineage committed progenitor; AD: adipocyte; CH: chondrocyte. (**C**) Violin plots of marker gene expression for indicated clusters in 3 and 16 month datasets. (**D**) Monocle (left) and Slingshot (right) trajectory plots of bone marrow mesenchymal lineage cells (excluding chondrocytes) in 3 and 16 month datasets. Cells are labeled according to their Seurat clusters. (**E**) An integrated tSNE plot of 1, 3, and 16 month datasets shows the clustering pattern. (**F**) An integrated tSNE plot of 1, 3, and 16 month datasets shows the distribution of each age group. (**G**) The percentages of mesenchymal progenitors before lineage commitment and adipocytes (ADs) within bone marrow mesenchymal lineage cells are quantified in each age group based on tSNE distribution.\
Figure 3---source data 1.Raw data for [Figure 3G](#fig3){ref-type="fig"}.](elife-54695-fig3){#fig3}

In summary, we conclude that the same pool of EMPs with the same hierarchy differentiation pattern is responsible for bone formation by mesenchymal lineage cells at adolescent, adult, and aging stages. During aging, EMPs are not only reduced in numbers but also drifted toward more adipogenic status, which might further account for the loss of progenitor activity.

Discovery of a novel adipogenic lineage cell population in bone {#s2-4}
---------------------------------------------------------------

The conventional view of bone marrow adipocytes is that they are Perilipin^+^ cells with a single large lipid droplet ([@bib15]). However, due to their large size and buoyance, those cells cannot be captured by pelleting and cell sorting. Furthermore, they are rare in the adolescent mouse bones. Therefore, we were surprised to identify a large cell cluster in young mice that express common adipocyte markers, including *Pparg, Cebpa, Adipoq, Apoe,* and *Lpl* ([Figure 4---figure supplement 1A, C](#fig4s1){ref-type="fig"}). However, they do not express *Plin1*, a gene encoding lipid droplet coating protein, and they express *Fabp4,* a gene encoding a fatty acid binding protein, at a very low level, implying that they do not contain lipid droplets. In addition, these cells express a variety of other group defining genes, such as *Lepr, Cxcl12, Il1rn, Serpina3g, Kng1, Kng2, Agt, Esm1,* and *Gdpd2* ([Figure 4---figure supplement 1B, D](#fig4s1){ref-type="fig"}). qRT-PCR analysis demonstrated that those genes are indeed up-regulated during adipogenic differentiation of mesenchymal progenitors in culture ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), supporting that cluster 7 in 1 month dataset represents adipose lineage cells.

To validate this population, we constructed adipocyte-specific *Adipoq-Cre* reporter mice: *Adipoq:Td* mice with or without *Col1a1-GFP* that labels osteoblasts. In line with the above sequencing data, there were many Td^+^ cells, existing either as CD45^-^ stromal cells or pericytes, in the bone marrow of newborn pups ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}) when long bone undergoes rapid bone formation. At 1 month of age, Td labeled all Perilipin^+^ adipocytes, CD45^-^ stromal cells with a reticular shape, and pericytes, but not osteoblasts, osteocytes, growth plate or articular chondrocytes ([Figure 4A](#fig4){ref-type="fig"}). The majority of Td^+^ cells did not harbor lipid droplets ([Figures 4B](#fig4){ref-type="fig"}, 1995 out of 2000 cells counted, n = 6 mice, 99.8%) and none of them incorporated EdU ([Figures 4C](#fig4){ref-type="fig"}, 0 out of 2060 cells counted, n = 3 mice, 0%). After isolated from bone marrow, Td^+^ cells attached to the culture dish but did not form CFU-F colonies ([Figures 4D](#fig4){ref-type="fig"}, 0 out of 100 colonies counted, n = 3 mice, 0%). In freshly isolated endosteal bone marrow, Td^+^ cells constituted about 18% of CD45^-^Ter119^-^ cells. During culture, the percentage of Td^+^ cells decreased progressively after cell passage (P0 when CFU-F colonies became confluent: 2.03%; P1: 0.93%: P2: 0.31%, by flow cytometry analysis), suggesting that those cells have much less proliferative ability if any compared to mesenchymal progenitors. Moreover, while freshly sorted Td^+^ cells from bone marrow of Col2:Td mice formed bone with a hematopoietic compartment after transplanted under mouse kidney capsule, freshly sorted Td^+^ cells from Adipoq:Td bone did not form bone-like structure ([Figure 4E](#fig4){ref-type="fig"}), demonstrating that they are not mesenchymal progenitors. This is consistent with the notion that *Adipoq-Cre* does not label adipoprogenitors in peripheral fat depots ([@bib25]). Indeed, the stromal vascular fraction (SVF) of visceral fat from Adipoq:Td mice contained no Td^+^ CFU-F colonies (data not shown).

![Mouse bone marrow contains abundant non-proliferative adipocyte precursors.\
(**A**) Representative fluorescent images of 1-month-old Adipoq:Td:Col1a1-GFP (**a--d**) or Adipoq:Td (**f--g**) femur reveal many bone marrow Td^+^ cells. (**a**) A low magnification image of a distal femur. (**b--g**) At a high magnification, Td does not label chondrocytes in articular cartilage (**b**) and growth plate (**c**), osteoblasts and osteocytes (arrows, **d**) but labels pericytes (arrows, **e**), Perilipin^+^ adipocytes (**f**), and CD45^-^ stromal cells (**g**). (**B**) According to BODIPY lipid staining, those Td^+^ stromal cells in a reticular shape (arrow) have no lipid accumulation. (**C**) In vivo EdU injection reveals that Td^+^ cells in Adipoq:Td mice do not proliferate. (**D**) CFU-F assay of bone marrow cells from Adipoq:Td mice shows that all CFU-F colonies are made of Td^-^ cells (**a**). (**b**) Some Td^+^ cells do attach to the dish but have minimum proliferation ability. n = 5 mice. (**E**) Endosteal bone marrow Td^+^ cells from 1-month-old Col2:Td mice (5 out of 5 transplants), but not Adipoq:Td mice (0 out of 3 transplants) form bone-like structure after transplanted under the kidney capsule. Representative fluorescent images of transplants were shown here. Osterix: osteoblasts; CD45: hematopoietic cells; Calcein: new bone surface. (**F**) In vitro adipogenic differentiation assay demonstrates that non-lipid-laden adipocytes exist as an intermediate state between mesenchymal progenitors and lipid-laden adipocytes. Mesenchymal progenitors, which are Td^-^, were obtained from culturing endosteal bone marrow cells from 1-month-old Adipoq:Td mice. Upon confluency, cells were cultured in adipogenic differentiation medium. The same area was imaged daily by inverted fluorescence microcopy. (**G**) CFU-F assay of bone marrow cells from P23 AdipoqER:Td mice (Tamoxifen injections at P14-16) shows that all CFU-F colonies are made of Td^-^ cells (**a**). (**b**) Some Td^+^ cells do attach to the dish but have minimum proliferation ability. n = 3 mice. (**H**) Immunofluorescence staining shows that Perilipin^+^bone marrow adipocytes are derived from non-lipid-laden adipocytes in 1-month-old AdipoqER:Td mice (Tamoxifen injections at P6, 7). (**I**) Representative images of co-localization of Td and Lepr in stromal (white arrows) and pericytes (yellow arrows) in bone marrow of 1-month-old Adipoq:Td mice.](elife-54695-fig4){#fig4}

To delineate the relationship among mesenchymal progenitors, non-lipid-laden Perilipin^-^Td^+^ cells, and lipid-laden Perilipin^+^Td^+^ cells, we subjected confluent mesenchymal progenitors from Adipoq:Td mice, which are Td^-^, to adipogenic differentiation. Interestingly, Td^-^ cells (day 0) became Td^+^ cells (days 1 and 2) with no lipid droplets and then evolved into Td^+^ cells with lipid accumulation (days 3--5, [Figure 4F](#fig4){ref-type="fig"}). For fate mapping in vivo, we generated *Adipoq-CreER Rosa26 \<lsl-tdTomato\>* (AdipoqER:Td) mice. Tamoxifen injections at P14-16 induced many Td^+^ cells in bone marrow at P23 with a similar distribution pattern as Td^+^ cells in Adipoq:Td mice ([Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}). All CFU-Fs from their bone marrow were Td^-^ and only a few Td^+^ cells attached to the dish without further proliferation ([Figure 4G](#fig4){ref-type="fig"}). AdipoqER:Td mice receiving Tamoxifen injections at P6-7, when no Perilipin^+^ adipocytes can be detected in the proximal tibia, displayed Perilipin^+^Td^+^ adipocytes at 1 month of age ([Figure 4H](#fig4){ref-type="fig"}), suggesting that Perilipin^-^Td^+^ cells become bone marrow adipocytes in vivo. Taken together, our data clearly demonstrate that non-lipid-laden, *Adipoq-Cre* labeled cells constitute a mesenchymal subpopulation situated after mesenchymal progenitors and before classic lipid-laden adipocytes (LiLAs) along the adipogenic differentiation route of bone marrow EMPs. As a further validation that *Adipoq-Cre* labeled cells are cells in cluster 7 of 1 month dataset, we stained sections with Lepr, a cluster 7 marker. As expected, almost all Td^+^ cells are Lepr^+^ as well ([Figure 4I](#fig4){ref-type="fig"}).

Compared to conventional adipose depots, we did not detect the expression of *Lep* (white adipocyte marker), *Ucp1* (brown adipocyte marker), *Tnfrsf9* (beige adipocyte marker) in cells of adipocyte cluster based on our sequencing data. Other adipose depot markers, such as *Hoxc8, Hoxc9* (white), *Cidea, Cox7a1, Zic1* (brown), *Cited1, Shox2, Tbx1* (beige) ([@bib9]; [@bib62]), were expressed either at very low level or ubiquitously among most mesenchymal lineage cells. Overall, our results indicate that bone marrow contains a unique, large population of adipogenic lineage cells that have no lipid storage.

A 3D network in bone marrow formed by *Adipoq*-labeled stromal cells and pericytes {#s2-5}
----------------------------------------------------------------------------------

In the bone marrow of young Adipoq:Td mice, Perilipin^-^Td^+^ cells far exceeded Perilipin^+^Td^+^ adipocytes in number. Cell counting in tibial sections revealed approximate 400:1 and 1000:1 ratios of Perilipin^-^Td^+^ cells to Perilipin^+^Td^+^ in the metaphyseal and diaphyseal bone marrow, respectively (n = 3 mice). Morphologically, Perilipin^-^Td^+^ cells exist as stromal cells and pericytes. PDGFRβ is a general pericyte marker ([@bib11]) and Laminin is a component of basement membrane secreted by both pericytes and endothelial cells ([@bib64]). Our scRNA-seq data showed that both *Pdgfrb* and *Lamb1* are expressed at relatively higher levels in the adipocyte cluster among all mesenchymal clusters ([Figure 5A](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Pericytes identified by PDGFRβ or Laminin staining in a peri-capillary location were Td^+^ (850 out of 850 cells counted, n = 3 mice, 100%, [Figure 5B](#fig5){ref-type="fig"}), indicating that *Adipoq* marks pericytes surrounding bone marrow capillaries. To further confirm their pericyte nature, we mixed sorted Td^+^ cells from Adipoq:Td bone marrow with endothelial progenitors and conducted vasculogenic tube assays. Strikingly, most Td^+^ cells co-localized with newly formed tubes ([Figure 5C](#fig5){ref-type="fig"}), suggesting that they function as pericytes. Consistent with this, the adipocyte cluster express many angiogenic factors, such as *Vegfa, Vegfc, Angpt4, Rspo3* etc ([Figure 5D](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Gene profiling of fractionated Td^+^ cells from Adipoq:Td bone marrow confirmed the remarkably high expression of these angiogenic factors as well as adipocyte markers and other newly identified markers ([Figure 5E](#fig5){ref-type="fig"}). Bone marrow pericytes seem to be unique because we did not observe Td^+^ pericytes in other tissues of Adipoq:Td mice, such as muscle, liver, lung, brain, heart, and kidney ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}).

![Non-lipid-laden Td^+^ cells in Adipoq:Td mice form a vast 3D network through their cell processes ubiquitously distributed inside the bone marrow.\
(**A**) The expression patterns of *Pdgfrb* and *Lamb1* are shown in tSNE plots. (**B**) Immunofluorescence staining reveals that all PDGFRβ^+^ and Laminin^+^ cells with a pericyte morphology are Td^+^ (pointed by arrows). (**C**) Td^+^ cells sorted from Adipoq:Td bone marrow act as pericytes after cocultured with bone marrow endothelial cells undergoing tube formation assay. (**D**) The expression patterns of angiogenic factors are shown in tSNE plots. (**E**) qRT-PCR analyses comparing mRNA levels in Td^+^ versus Td^-^ cells (set as 1) sorted from bone marrow of 1-month-old Adipoq:Td mice confirm that *Adipoq-Cre* labeled cells highly express angiogenic factors, known adipocyte markers, and novel markers suggested by sequencing data. \*: p\<0.05; \*\*: p\<0.01; \*\*\*: p\<0.001 Td^+^ vs Td^-^, n = 3 mice. (**F**) A 3D network in bone marrow formed by Td^+^ stromal cells and pericytes in 1-month-old Adipoq:Td mice. (**a**) A low magnification image reveals the network of Td^+^ cells in the femoral bone marrow. (**b**) Td^+^ cell bodies and their processes are more obvious in a high magnification image. See [Figure 5---video 1](#fig5video1){ref-type="video"} for a 3D structure. (**c**) Those Td^+^ cells have PDGFRβ staining all over their cell processes. See [Figure 5---video 2](#fig5video2){ref-type="video"} for a 3D structure. (**d**) They also have punctuated Connexin 43 staining in their process, indicating cell-cell communication. See [Figure 5---video 3](#fig5video3){ref-type="video"} for a 3D structure. (**e**) Td^+^ pericytes have cell processes. Some processes protrude into bone marrow just like those of Td^+^ stromal cells and some of them wrap around the vessel wall. Similarly, Td^+^ stromal cells also extend their processes toward vessels either wrapping around the vessel wall (yellow triangles) or contacting the processes from pericytes. White arrows point to cells with a typical pericyte morphology. A blue arrow points to a Td^+^ cell sitting on a vessel with a stromal cell shape. Therefore, considering the presence of cell processes and connections, Td^+^ stromal cells and pericytes are indeed very similar. See [Figure 5---video 4](#fig5video4){ref-type="video"} for a 3D structure. (**f**) Cell processes from Td^+^ cells touch almost every CD45^+^ hematopoietic cells inside bone marrow. (**g**) They also reach trabecular bone surface. (**h**) On the contrary, most cell surface of Perilipin^+^Td^+^ adipocytes are smooth and round. See [Figure 5---video 5](#fig5video5){ref-type="video"} for a 3D structure.\
Figure 5---source data 1.Raw data for [Figure 5E](#fig5){ref-type="fig"}.](elife-54695-fig5){#fig5}

Interestingly, when we scanned 50 µm-thick sections of Adipoq:Td long bones, we observed a striking 3D network made of cell processes from Td^+^ cells that were ubiquitously distributed inside bone marrow ([Figure 5Fa, b](#fig5){ref-type="fig"}, [Figure 5---video 1](#fig5video1){ref-type="video"}). In sharp contrast to round hematopoietic cells, Td^+^ stromal cells and pericytes possessed an average of 6.1 ± 0.2 cell processes (52 cells counted, n = 3 mice), which were covered by cell membrane proteins, such as PDGFRβ and gap junction Connexin 43 ([Figure 5Fc](#fig5){ref-type="fig"}, d, [Figure 5---videos 2](#fig5video2){ref-type="video"} and [3](#fig5video3){ref-type="video"}). These processes were reminiscent of osteocytic canaliculi structure, although they are much longer and more disorientated. With these processes, Td^+^ stromal cells and pericytes were morphologically similar ([Figure 5Fe](#fig5){ref-type="fig"}, [Figure 5---video 4](#fig5video4){ref-type="video"}). They all extended cell processes into the marrow, making numerous connections amongst themselves, around endothelial walls ([Figure 5Fe](#fig5){ref-type="fig"}), with hematopoietic cells ([Figure 5Ff](#fig5){ref-type="fig"}), and with bone surface ([Figure 5Fg](#fig5){ref-type="fig"}). In LiLAs, cell processes were only detected at a small portion of cell surface next to cytoplasm and nuclei but not at the most part of cell surface next to the lipid droplet ([Figure 5Fh](#fig5){ref-type="fig"}, [Figure 5---video 5](#fig5video5){ref-type="video"}). The vast 3D structure of Td^+^ cells implies a unique communication role.

The critical function of *Adipoq*-labeled cells in bone {#s2-6}
-------------------------------------------------------

We next sought to study the function of these Td^+^ cells by ablating them in 1-month-old *Adipoq-Cre Rosa26 \<lsl-tdTomato\>DTR* (Adipoq:Td:DTR) mice via diphtheria toxin (DT) injections. After two weeks, DT-treated mice displayed pale bones as compared to vehicle-treated mice ([Figure 6A](#fig6){ref-type="fig"}). In bone marrow Perilipin^+^Td^+^ and Perilipin^-^Td^+^ cells were greatly reduced by 95% and 88%, respectively ([Figure 6B,C](#fig6){ref-type="fig"}). Bone marrow vasculature underwent severe pathological changes, becoming dilated and distorted ([Figure 6D,E](#fig6){ref-type="fig"}). Quantification revealed 2.3- and 1.9-fold increases in vessel diameter and vessel area, respectively, and a 36% decrease in vessel density ([Figure 6F](#fig6){ref-type="fig"}). Additionally, the number of Emcn^+^CD31^+^ endothelial cells decreased by 45% after DT treatment ([Figure 6G](#fig6){ref-type="fig"}). In bone marrow, *Adipoq-Cre* labeled a similar density of pericytes as *Col2-Cre* (0.0172 ± 0.0019 vs 0.0174 ± 0.0028 pericytes/µm vessel length, n = 3 mice/group). Strikingly, DT injections drastically decreased Td^+^ pericytes by 90% to 0.0018 ± 0.0005 pericytes/µm vessel length (n = 3 mice/group, [Figure 6E](#fig6){ref-type="fig"}). Hence, one role of these non-lipid laden Td^+^ cells is to maintain normal bone marrow vessels.

![Bone marrow Adipoq^+^ cells are critical for supporting marrow vasculature.\
(**A**) Ablation of *Adipoq-Cre* labeled cells changes the color of long bones from red to pink. One-month-old Adipoq:Td:DTR mice received either veh or DT injections (50 μg/kg) every other day for 2 weeks and long bones were harvested for analysis. (**B**) Inside the long bone, Td^+^ cells were significantly reduced by DT injections. (**C**) Perilipin^+^ adipocytes were also diminished by DT injections. (**D**) Fluorescent images of vessel staining in femur at a low magnification revealed abnormal bone marrow vessel structure after DT injections. (**E**) Fluorescent images of vessel staining in femur at a high magnification showed that vessels were dilated coinciding with the depletion of Td^+^ pericytes (arrows) after DT injections. (**F**) Vessel diameter, area, and density are quantified in the central bone marrow. n = 3 mice. \*\*\*: p\<0.001 DT vs veh. (**G**) Flow cytometric analysis of endothelial cells (Emcn^+^CD31^+^) in bone marrow after DT injections.\
Figure 6---source data 1.Raw data for [Figure 6F](#fig6){ref-type="fig"}.](elife-54695-fig6){#fig6}

The color change in bone after cell ablation was due to de novo trabecular bone formation throughout the marrow cavity, especially in the diaphysis that is normally devoid of any trabeculae ([Figure 7A--C](#fig7){ref-type="fig"}). MicroCT quantification of newly formed bone in the diaphyseal region revealed that it resembles metaphyseal trabecular bone in normal mice ([Figure 7D](#fig7){ref-type="fig"}). Numerous Osterix^+^ osteoblasts were observed inside the diaphyseal bone marrow ([Figure 7E](#fig7){ref-type="fig"}), suggesting that osteogenic differentiation is rapidly activated. The fact that nearly all osteoblasts are Td^-^ further confirmed that *Adipoq-Cre* rarely labels mesenchymal progenitors that generate osteoblasts. Furthermore, DT injections drastically reduced CFU-F frequency from bone marrow ([Figure 7F](#fig7){ref-type="fig"}), suggesting a direct or indirect effect of Td^+^ cells on progenitors. The new bone formation along the endosteal surface of cortical bone was mostly woven bone with misaligned collagen fibrils ([Figure 7G](#fig7){ref-type="fig"}). This resulted in increased cortical thickness and area, reduced endosteal perimeter, and low tissue mineral density ([Figure 7H](#fig7){ref-type="fig"}).

![Bone marrow Adipoq^+^ cells inhibit bone formation.\
(**A**) 3D μCT images of Adipoq:Td:DTR femurs reveal drastic de novo bone formation in the midshaft region after 2 weeks of DT injections. (**B**) H and E staining of femoral sections. (**C**) 3D reconstructed microCT images of femoral midshaft region. (**D**) MicroCT measurement of trabecular bone structural parameters from the midshaft region. BV/TV: bone volume fraction; Tb.N: trabecular number; Tb.Th: trabecular thickness; Tb.Sp: trabecular separation; Conn.D: connective density; SMI: structural model index. n = 6 mice/group. \*: p\<0.05; \*\*\*: p\<0.001 DT vs veh. (**E**) Fluorescent image shows that newly formed osteoblasts (Osterix^+^ cells) in the diaphyseal bone marrow are Td^-^ cells. (**F**) CFU assay demonstrates a decrease in mesenchymal progenitors in Adipoq:Td:DTR femurs after DT injections. n = 3 mice/group. \*\*\*: p\<0.001 DT vs veh. (**G**) Second harmonic generation images of femoral sections reveal that collagen fibers in the newly formed bone on the endocortical surface are mostly misaligned in Adipoq:Td:DTR mice after DT injections. (**H**) MicroCT measurement of cortical bone structural parameters from the midshaft region. Ps.Pm: periosteal perimeter; Ec.Pm: endosteal perimeter; Ct.Th: cortical thickness; Ct.Ar: cortical area; Ct.TMD: cortical tissue mineral density. n = 6 mice/group. \*: p\<0.05; \*\*: p\<0.01; \*\*\*: p\<0.001 DT vs veh.\
Figure 7---source data 1.Raw data for [Figure 7D](#fig7){ref-type="fig"}.\
Figure 7---source data 2.Raw data for [Figure 7H](#fig7){ref-type="fig"}.](elife-54695-fig7){#fig7}

After DT treatment, the overall bone marrow cellularity was significantly decreased ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}). However, the hematopoietic components, including hematopoietic stem/progenitors cells and lineage specific cells, as well as peripheral blood components, remained largely unaltered ([Figure 7---figure supplement 1B, C](#fig7s1){ref-type="fig"}). Therefore, the reduced cellularity is likely caused by the smaller marrow cavity secondary to the new bone formation.

Non-lipid-laden Td^+^ cells were also abundant in the vertebrae of adolescent mice ([Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"}). After cell ablation in Adipoq:Td:DTR mice, bone marrow vasculature was similarly distorted ([Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}), and osteogenic cells were similarly increased ([Figure 7---figure supplement 2C](#fig7s2){ref-type="fig"}), leading to elevated trabecular bone mass ([Figure 7---figure supplement 2D, E](#fig7s2){ref-type="fig"}). Note that DT injection alone did not alter bone structure in long bones or vertebrae of Adipoq:Td mice (data not shown).

*Adipoq-Cre* also targets peripheral fat depots. A recent study on 'fatless' mice (*Adipoq-Cre DTA*) reported that circulating adiponection and leptin released by subcutaneous adipocytes negatively regulate bone formation ([@bib68]). To investigate whether a similar mechanism occurs in our cell ablation model, we transplanted *WT* subcutaneous fat to Adipoq:Td:DTR mice and performed DT injections 2 weeks later. While DT injections greatly increased blood glucose level, this increase was abolished by fat transplantation ([Figure 7---figure supplement 3A](#fig7s3){ref-type="fig"}), suggesting a successful restoration of peripheral fat in DT-treated mice. Interestingly, in our mouse model, fat transplantation did not appear to affect DT-induced vessel damage and de novo formation in the diaphysis bone marrow ([Figure 7---figure supplement 3B-E](#fig7s3){ref-type="fig"}), suggesting that peripheral fat tissues are not involved in the drastic changes in Adipoq:Td:DTR bone after DT injections.

Taken together, our data indicate that these *Adipoq-Cre* labeled, non-lipid-laden cells are a critical bone marrow component regulating their environment, including marrow vasculature and bone formation. Therefore, we name this new type of adipogenic lineage cell as marrow adipogenic lineage precursors (MALPs).

Discussion {#s3}
==========

In this study, we computationally delineated the entire in vivo differentiation process of mesenchymal progenitors and defined the mesenchymal lineage hierarchy inside bone marrow ([Figure 8](#fig8){ref-type="fig"}). Stem cell heterogeneity and plasticity have been recognized in some well-studied mammalian tissue stem cells ([@bib54]). However, in the past, owing to a lack of discerning investigative tools, we purposely ignored these features of mesenchymal lineage cells by simply referring to all progenitors as MSCs or mesenchymal progenitors and searching for one or a set of marker(s) to cover all of them. Our work computationally addresses this long-standing uncertainty and clarifies the expression patterns of previously proposed MSC markers in mesenchymal subpopulations.

![A schematic diagram depicts a model of bone marrow mesenchymal lineage cells and the role of MALPs.\
OB: osteoblast; Ocy: osteocyte; EMP: early mesenchymal progenitor; LMP: late mesenchymal progenitor; LCP: lineage committed progenitors; MALPs: marrow adipogenic lineage precursors; LiLA: lipid-laden adipocytes.](elife-54695-fig8){#fig8}

It is generally believed that during organ homeostasis, a small number of quiescent, self-renewing stem cells give rise to a large number of fast-proliferating, non-renewing progenitor cells, which then mature into various terminally differentiated cell types. This unidirectionality guarantees that different cell types in an organ have distinct identities and play specialized functions. Our proposed mesenchymal progenitors at different stages and their bi-lineage differentiation routes based on scRNA-seq analysis are consistent with the above concept. Specifically, at various ages, the EMPs cluster always has the least number of cells among all mesenchymal cell clusters and is always situated at one end of trajectory. Moreover, it shrinks in size during aging. Compared to other progenitors, they are less proliferative and they do not express lineage master regulators, such as *Runx2*, *Sp7*, *Cebpa*, or *Pparg*. Instead, they express constellation of group-defining genes, including *Ly6a*, *Cd34*, and *Thy1*, which have been shown to mark other adult stem cells, such as HSCs, keratinocyte stem cells, cancer stem cells, muscle stem cells etc ([@bib50]; [@bib59]; [@bib47]; [@bib36]). Along the differentiation routes of progenitors, the expression levels of lineage specific genes, such as *Bglap2*, *Col1a1*, *Ibsp*, *Adipoq,* and *Apoe*, progressively increase. The EMP cells in our dataset are also consistent with a previous study showing that mouse bone marrow Sca1^+^PDGFRα^+^CD45^-^Ter119^-^ cells generate colonies at a high frequency and differentiate into hematopoietic niche cells, osteoblasts, and adipocytes after in vivo transplantation ([@bib35]). Nevertheless, future lineage tracing experiments are required to demonstrate that cells in the EMP cluster give rise to cells in LMP and LCP clusters, and resultant terminally differentiated cells in vivo.

Using a lineage tracing approach (*Lepr-Cre* mice), ([@bib65]) previously showed that Lepr labels bone marrow mesenchymal progenitors in adult mice (6 months of age) but not in young mice. Our study identified Lepr is a marker for MALPs, which are non-proliferative cells expressing adipocyte genes. We also observed that *Lepr* express in EMP cluster at a low level in young and adult mice and at a high level in old mice. The increased *Lepr* expression in EMP cluster during aging might explain the previous observations that Lepr marks MSCs in adult mice but not in young mice and that Lepr labels marrow adipocytes from a young age ([@bib65]). In the same study, it was reported that Lepr^+^ cells constitute 0.3% of bone marrow cells. Since bone marrow CFU-F frequency is less than 0.01% in adult mice, these data clearly indicate that Lepr labels much more cells than progenitors. Our aging sequencing data showing the great expansion of Lepr^+^ MALP cluster in 16-month-old mice further excludes the use of Lepr as a mesenchymal progenitor marker because it conflicts with the well-known aging effect on reducing the pool of bone marrow mesenchymal progenitors. Therefore, we believe that Lepr^+^ cells in bone marrow are a heterogeneous population whose majority is MALPs and minority is mesenchymal progenitors. This is further confirmed by another scRNA-seq study analyzing *Lepr-Cre* labeled bone marrow cells ([@bib55]) (GSE108892, Portals available from <http://aifantislab.com/niche>). In that study, two large clusters, *Mgp*^High^ P1 and *Lpl*^High^ P2, highly express adipogenesis-associated genes, and two small clusters are similar to our LCP and OB clusters ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). A recent scRNA-seq analysis of Ter119^-^CD71^-^Lin^-^bone marrow cells from *WT* mice ([@bib3]) (GSE128423, Portals available from <https://portals.broadinstitute.org/single_cell/study/mouse-bone-marrow-stroma-in-homeostasis>) generated a similar clustering pattern and gene expression signature as ours, demonstrating the robustness of scRNA-seq methodology of identifying bone marrow mesenchymal populations. The Lepr-MSC cluster identified in that study highly and specifically expresses many known and newly identified adipocyte markers of MALPs ([Figure 8---figure supplement 2A](#fig8s2){ref-type="fig"}). Interestingly, among five fibroblast cell clusters identified in that study, 2 of them have a similar set of gene signatures as our EMPs and the other three overlap with LMPs ([Figure 8---figure supplement 2B](#fig8s2){ref-type="fig"}).

Bone marrow adipose tissue (MAT) refers to MSC-derived adipocytes located within the bone marrow niche ([@bib58]). Different from their counterparts in white adipose tissue (WAT) and brown adipose tissue (BAT), adipocytes in MAT are interspersed at a much lower density by hematopoietic, endothelia, and osteogenic cells. To date, MAT research has focused on LiLAs and their roles in energy metabolism ([@bib22]), energy deficit ([@bib14]), diabetes ([@bib21]), and cancer metastasis ([@bib28]). Since LiLAs are rare in the bone marrow of healthy young mice, MAT is mainly studied in the context of diseases and aging. Based on our computational data, we uncovered a novel type of adipogenic lineage cell, MALPs, that expresses many adipocyte markers, but lacks significant lipid stores. Our trajectory analysis, in vitro adipogenic differentiation assay, and in vivo fate mapping data provide strong evidence that MALPs represent a stable transitional cell type along the adipogenic differentiation route after mesenchymal progenitors and before LiLAs. The relationship between MALPs and LiLAs is similar to that between osteoblasts and osteocytes as both MALPs and osteoblasts are functional precursors for terminally differentiated cells. Therefore, our study expands the concept of MAT to include MALP, an abundant cell type, and its regulatory functions in bone.

In traditional adipose depots, adipogenic differentiation is tightly coupled with lipid accumulation. Single cell analyses of murine or human white fat depots (visceral or subcutaneous) did not identify cell populations analogous to MALPs ([@bib31]). Pre-adipocytes from adult tissues express low levels of *Pparg* but not *Adipoq*, and are also defined by their expression of canonical mesenchymal progenitor markers, including *Sca1* and *Cd34* ([@bib4]). In contrast, MALPs do not proliferate and do not express progenitor markers. Instead, they express many known and newly identified markers of terminally differentiated adipocytes. Therefore, MALPs represent a cell type distinct from traditional pre-adipocytes. Under physiology conditions, MALPs are hundreds to a thousand times more than LiLAs, indicating that they are a stable population rarely converted into LiLAs. Whether they can directly undergo apoptosis without differentiated into LiLAs needs further investigation. It will also be interesting to identify the molecular mechanism that blocks a large number of cells at MALP stage without becoming LiLAs. We speculate that MALPs are poised to accumulate lipid and become LiLAs in response to metabolic or other cues, such as radiation injury and the availability of fatty acids. Overall, we conclude that MALPs represent a marrow-specific type of adipose cell that plays unique roles in regulating their bone environment. One limitation of our study is that we do not have a *Cre* specific for MALPs. Therefore, we could not rule out the potential influence of LiLAs in cell ablation experiments. Since MALPs are hundreds times more than LiLAs in young mice, we believe that the later one has a minor role compared to the former one.

Morphologically and functionally, MALPs are also different from traditional round shape adipocytes. Even in young mice, MALPs exist in abundant amount as marrow stromal cells or pericytes. Importantly, their cell processes form a vast 3D network structure inside bone marrow, making numerous contacts among themselves and with the rest of bone marrow components. Most likely through secreting factors into their marrow environment, they play pivotal roles in maintaining marrow vasculature and suppressing osteogenic differentiation of mesenchymal progenitors. Although we did not detect any changes in hematopoietic components shortly after ablation of MALPs, we still believe that they have the ability of controlling hematopoiesis because of several reasons. First, Cxcl12, a chemokine responsible for the retention of hematopoietic progenitors ([@bib43]), is the 2^nd^ most expressed genes in MALPs. Previous studies have shown that Cxcl12-abundant reticular (CAR) cells act as a niche for HSCs ([@bib53]). Indeed, due to their high Cxcl12 expression and reticular morphology, MALPs likely constitute a significant portion of CAR cells. Second, it has been shown that Scf from *Adipoq-CreER* or *Lepr-Cre* labeled bone marrow cells promotes hematopoietic regeneration after injury ([@bib66]). According to our datasets, Scf is highly and specifically expressed in MALPs. Hence, a prolonged cell ablation period or an injury might be required to detect the regulatory action of MALPs on hematopoiesis inside the bone marrow.

In the literature, pericytes are commonly refer to cells embedded within the basement membrane of microvessels, including capillaries, postcapillary venules, and terminal arterioles ([@bib1]). Our study of MALPs challenges the concept that pericytes must be tightly associated with endothelial cells. In the 3D bone marrow images of Adipoq:Td mice, while many Td^+^ cells display a typical pericytic morphology with extensive cell body attachment to endothelial cells, there were also Td^+^ cells that did not have this canonical morphology. Instead, they have a stromal cell morphology and contact endothelial cells through a small portion of their cell bodies as well as through extended processes. Moreover, many Td^+^ stromal cells with no cell body contact with endothelial cells extend their cell processes to wrap around capillaries walls. Therefore, these observations indicate that both pericytes and stromal cells wrap around vessels and contribute to vessel stabilization and maintenance.

The main functions of currently known adipocytes are lipid storage, thermogenesis, and regulation of nutrient homeostasis. Apparently, MALPs are unconventional possessing a completely different set of functions. Why bone marrow mesenchymal progenitors need to turn on adipocyte transcriptome in order to become a central regulator of bone marrow environment is an interesting question. Furthermore, future studying the underlying molecular mechanisms by which they regulate their environment will shed light on identifying new drugs for treating bone diseases such as osteoporosis.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                     Designation                                Source or reference                                              Identifiers          Additional\
  (species) or resource                                                                                                                                              information
  --------------------------------- ------------------------------------------ ---------------------------------------------------------------- -------------------- ------------------------------------------------------------------------------------------------------
  Genetic reagent (*M. musculus*)   *Col2-Cre*                                 PMID:[10686612](https://www.ncbi.nlm.nih.gov/pubmed/10686612)                         

  Genetic reagent (*M. musculus*)   *Dmp1-Cre*                                 PMID:[22623172](https://www.ncbi.nlm.nih.gov/pubmed/22623172)                         

  Genetic reagent (*M. musculus*)   *Adipoq-Cre*                               PMID:[21356515](https://www.ncbi.nlm.nih.gov/pubmed/21356515)                         

  Genetic reagent (*M. musculus*)   *Acta2-CreER*                              PMID:[18571490](https://www.ncbi.nlm.nih.gov/pubmed/18571490)                         

  Genetic reagent (*M. musculus*)   *Col1a1-GFP*                               PMID:[11771662](https://www.ncbi.nlm.nih.gov/pubmed/11771662)                         

  Genetic reagent (*M. musculus*)   Rosa26 iDTR                                Jackson Laboratory                                                                    

  Genetic reagent (*M. musculus*)   *Rosa26*                                   Jackson Laboratory                                                                    

  Antibody                          goat anti-mouse LepR                       R and D system                                                   Cat.\#: AF497        IF(1:200)

  Antibody                          rabbit anti-mouse Laminin                  Sigma                                                            Cat.\#: L9393        IF(1:200)

  Antibody                          rat anti-mouse CD45                        Biolegend                                                        Cat.\#: 103101       IF(1:200)

  Antibody                          rat anti-mouse\                            Santa cruz                                                       Cat.\#: sc 65495     IF(1:200)
                                    Endomucin                                                                                                                        

  Antibody                          rabbit anti-Osterix                        Abcam                                                            Cat.\#: ab22552      IF(1:200)

  Antibody                          rabbit anti-Perilipin                      Cell signaling                                                   Cat.\#: 9349         IF(1:200)

  Antibody                          rat anti-mouse PDGFRβ                      Biolegend                                                        Cat.\#: 136002       IF(1:100)

  Antibody                          rabbit anti-mouse connexin 43              Cell signaling                                                   Cat.\#: 3512         IF(1:100)

  Antibody                          FITC rat anti-mouse\                       Santa cruz biotechology                                          Cat.\#: sc-65495     Flow analysis (1:100)
                                    Endomucin                                                                                                                        

  Antibody                          rat anti-Gr-1 APC-Cy7,                     BD                                                               Cat.\#: 557661       Flow analysis (1:100)

  Antibody                          rat anti-Mac-1 APC                         eBioscience                                                      Cat.\#: 17-0112-83   Flow analysis (1:100)

  Antibody                          rat anti-B220 FITC                         eBioscience                                                      Cat.\#: 11-0452-82   Flow analysis (1:100)

  Antibody                          hamster anti-CD3 PE-Cy7                    eBioscience                                                      Cat.\#: 25-0031-82   Flow analysis (1:100)

  Antibody                          APC rat anti-mouse CD31                    Biolegend                                                        Cat.\#: 561814       Flow analysis (1:100)

  Antibody                          Click-iT EdU Alexa Fluor 647 Imaging Kit   Thermo Fisher                                                    Cat.\#: D3822        

  Peptide, recombinant protein      Calcein                                    Sigma                                                            Cat.\#: C0875        15 mg/kg forin vivo injection

  Chemical compound, drug           Diphtheria toxin                           Sigma-Aldrich                                                    Cat.\#: D0564-1MG    50 µg/kg forin vivo injection

  Chemical compound, drug           ACK lysing buffer                          ThermoFisher Scientific                                          Cat.\#: A1049201     500 ul/ 50 million cells

  Software, algorithm               Cellranger 3.02                                                                                                                  <https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/installation>

  Software, algorithm               Seurat V2, V3                              PMID:[25867923](https://www.ncbi.nlm.nih.gov/pubmed/25867923)\                        <https://satijalab.org/seurat/>
                                                                               PMID:[31178118](https://www.ncbi.nlm.nih.gov/pubmed/31178118)                         

  Software, algorithm               Monocle V2                                 PMID:[24658644](https://www.ncbi.nlm.nih.gov/pubmed/24658644)                         <http://cole-trapnell-lab.github.io/monocle-release/docs>

  Software, algorithm               Slingshot 1.5.1                            PMID:[29914354](https://www.ncbi.nlm.nih.gov/pubmed/29914354)                         <https://bioconductor.org/packages/devel/bioc/vignettes/slingshot/inst/doc/vignette.html>

  Other                             BODIPY dye                                 ThermoFisher scientific                                          D3822                IF (1:500)
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ethics statement {#s4-1}
----------------

All animal work performed in this report was approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Pennsylvania under Protocol 804112. University Laboratory Animal Resources (ULAR) of the University of Pennsylvania is responsible for the procurement, care, and use of all university-owned animals as approved by IACUC. Animal facilities in the University of Pennsylvania meet federal, state, and local guidelines for laboratory animal care and are accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International.

Animal study design {#s4-2}
-------------------

*Col2-Cre Rosa26 \<lsl-tdTomato\>* (Col2:Td), *Dmp1-Cre Rosa26 \<lsl-tdTomato\>* (Dmp1:Td), *Adipoq-Cre Rosa26 \<lsl-tdTomato\>* (Adipoq:Td), *Adipoq-CreER Rosa26 \<lsl-tdTomato\> (*AdipoqER:Td), and *Acta2-CreER Rosa26 \<lsl-tdTomato\>* (Acta2ER:Td) mice were generated by breeding *Rosa26 \<lsl-tdTomato\>* (Jackson Laboratory, Bar Harbor, ME, USA) mice with *Col2-Cre* ([@bib41]), *Dmp1-Cre* ([@bib27]), *Adipoq-Cre* ([@bib12]), *Adipoq-CreER* ([@bib17]), and *Acta2-CreER* ([@bib19]) mice respectively. *Adipoq-Cre Rosa26 \<lsl-tdTomato\>Col1a1-GFP* (Adipoq:Td:Col1-GFP) were generated by breeding Adipoq:Td mice with *Col1a1-GFP* mice ([@bib18]). For lineage tracing experiments, mice received Tamoxifen injections (75 mg/kg/day) at indicated age and their bones were harvested later. *Adipoq-Cre Rosa26 \<lsl-tdTomato\>DTR* (Adipoq:Td:DTR) mice were generated by breeding Adipoq:Td mice with *DTR* mice (Jackson Laboratory). Mice received vehicle (1xPBS) or DT injections (50 µg/kg) every other day for 2 weeks. Bones were harvested at indicated times for histology and microCT analysis.

For in vivo transplantation of mesenchymal cells, freshly FACS-sorted Td^+^ cells (5 × 10^4^/transplant) were mixed with Gelfoam and placed under the kidney capsule of recipient 2-month-old *C57Bl/6* mice. The transplant grafts were harvested 4 weeks post-transplantation for histology analysis. Mice received calcein injection (15 mg/kg) at 1 day prior to euthanization.

For fat transplantation, donor fat pads from *WT* siblings were cut into 100--150 mg pieces and subcutaneously implanted into 1 month old Adipoq:Td:DTR mice through small incisions in the skin with one piece per incision and six pieces per mouse as described previously ([@bib68]; [@bib13]). Two weeks later, Adipoq:Td:DTR mice received vehicle or DT injections (50 µg/kg) every other day. At 1 week after starting DT injections, mice were starved for 6 hr followed by blood glucose measurement using a drop of tip tail blood. At 2 weeks after starting DT injections, mice were euthanized to harvest bones.

Endosteal bone marrow Td^+^ cell isolation and cell sorting {#s4-3}
-----------------------------------------------------------

Endosteal bone marrow cells were harvested as described previously ([@bib67]). Briefly, the outer surfaces of long bones were scraped and digested to remove the periosteum. After cutting off the epiphyses and flushing out the central bone marrow, metaphyseal bone fragments were longitudinally cut into two halves and digested by proteases to collect endosteal bone marrow cells. Freshly isolated endosteal bone marrow cells were resuspended into FACS buffer containing 25 mM HEPES (Thermofisher scientific) and 2% FBS in PBS and sorted for top 1% Td^+^ cells if a Td peak was not obvious or Td^+^ cells if a Td peak was obvious using Influx B (BD Biosciences, San Jose, CA) or Aria B (BD Biosciences, San Jose, CA).

Single-cell RNA sequencing of endosteal bone marrow cells {#s4-4}
---------------------------------------------------------

We constructed 4 batches of single cell libraries for sequencing: endosteal Td^+^bone marrow cells from 1-month-old (n = 2), 1.5-month-old (n = 3), 3-month-old (n = 3) and 16-month-old (n = 3) male Col2:Td mice. 20,000 cells were loaded in aim of acquiring one single library of 10,000 cell for each age group by Chromium controller (V3 chemistry version, 10X Genomics Inc, San Francisco, USA), barcoded and purified as described by the manufacturer, and sequenced using a 2 × 150 pair-end configuration on an Illumina HiSeq platform at a sequencing depth of \~400 million reads. Cell ranger (Version 3.0.2, <https://support.10xgenomics.com/single-cell-geneexpression/software/pipelines/latest/what-is-cell-ranger>) was used to demultiplex reads, followed by extraction of cell barcode and unique molecular identifiers (UMIs). The cDNA insert was aligned to a modified reference mouse genome (mm10). Doublets or cells with poor quality (genes \> 6000, genes \< 200, or \>5% genes mapping to mitochondrial genome) were excluded. Expression was natural log transformed and normalized for scaling the sequencing depth to a total of 1 × 10^4^ molecules per cell, followed by regressing out the number of UMIs and percent mitochondrial genes using Seurat V2 ([@bib45]).

For the integrated dataset, canonical component analysis (CCA) ([@bib5]) was performed using the union of the top 2000 genes with the highest dispersion from both datasets and to determine the common sources of variation between 1- and 1.5 month datasets. A CCA dimensional reduction was subsequently generated on the basis of the first 30 canonical correlation vectors. T-distributed stochastic neighbor embedding (tSNE) plots were used to visualize the data based on the CCA alignment. Cluster specific markers for each cluster, relative to the remaining population, were conducted using the FindMarkers to identify differentially expressed genes (DEGs). Sub-clustering was performed by isolating the mesenchymal lineage clusters identified from the remaining bone marrow cells using known marker genes, followed by reanalysis as described above. This resulted in the generation of 9 clusters. Because chondrocytes are derived from the growth plate, not bone marrow, these chondrocyte clusters were excluded from further analyses. DEGs between these clusters were generated as described above. GO terms and KEGG pathway enrichment, were identified using the database for annotation, visualization and integrated discovery (DAVID) ([@bib16]).

For individual analysis of the 3- and 16-month-old dataset, Seurat package V3 ([@bib52]) was used for filtering, variable gene selection, dimensionality reduction analysis and clustering standardly. Poor quality cells or doublets were first filtered as described above, followed by identifying the variable genes by default FindVariableFeatures function. Next, we performed principal component analysis (PCA) using the JackStraw function. Statistically significant PCs were selected as input for tSNE or uniform manifold approximation and projection (UMAP) plots. For sub-clustering, we repeated the same procedure of ﬁnding variable genes, dimensionality reduction, and clustering. Different resolutions for clustering have been tested to demonstrate the robustness of clusters.

To analyze 4 datasets from different age group, we applied Seurat V3 ([@bib52]) for performing integrated analyses to identify common cell types. 1-month-old and 1.5-month-old dataset were combined as 1M data, 3-month-old and 16-month-old dataset were input as 3M/16M data. Anchors from different dataset were defined using the FindIntegrationAnchors function, then use these anchors to integrate all datasets together with IntegrateData. This integrated data was further analyzed and subclustered for mesenchymal lineage cells as described above.

For cell cycle analysis, we used a core set of 43 S and 54 G2/M genes defined previously ([@bib56]). First, the genes that are expressed in less than 5% of total cells were removed, resulting in 34 S and 45 G2/M genes for the following cell cycle analysis. Second, we define proliferative cells if the cell express one gene set significantly more than the other. Since the null distribution for the S gene set and G2/M gene set is unknown, we designed a nonparametric permutation test. To be more specific, for each cell, we resampled 34 genes from the 79 genes (34+45) as 'S genes' and the rest 45 genes as 'G2/M genes'. This resampling was repeated 5000 times and each time, we calculate the difference between the mean expression value of 'S genes' and the mean expression values of 'G2/M genes'. The original difference between the mean expression value of S genes and the mean expression value of G2M was compared with the difference between resampling results to get a significant score (p-values). To correct for multi-test, FDR corrections were applied to each cluster. At last, FDR p-value\<0.05 was used as a cutoff for distinguishing proliferative or non-proliferative cells.

To computationally delineate the developmental progression of bone marrow mesenchymal cells and order them in pseudotime, we used the algorithms implemented in the Monocle V2 package ([@bib57]). We include the mesenchymal lineage cells with no chondrocytes from separated or integrated dataset of different age (1, 3 and 16 month old) mice for the analysis. We ordered cells by selecting genes with high dispersion across cells, using a parameter of 'mean_expression \>= 0.05 and dispersion_empirical \>= 2 \* dispersion_fit', lists of genes were selected for dimensional reduction to generate the trajectory reconstruction using the nonlinear reconstruction algorithm DDRTree. Branched expression analysis modeling, or BEAM ([@bib57]) was used to determine the genes that are differentially expressed between the osteogenic or adipogenic branches. A mouse transcript factors (TF) list (TFdb) ([@bib20]) were used to detect 385 TFs among the differential expressed genes.

We also performed the trajectory analysis using Slingshot ([@bib51]). Briefly, UMAP was used as dimensional reduction after the PCA were calculated for individual or integrated datasets. Then Seurat objects were transformed into SingleCellExperiment objects. Slingshot trajectory analysis was conducted using the Seurat clustering information and with dimensionality reduction produced by UMAP.

Histology {#s4-5}
---------

To obtain whole mount sections for immunofluorescent imaging, freshly dissected bones (femurs, tibiae, L4/L5 vertebrae) were fixed in 4% PFA for 1 day, decalcified in 10% EDTA for 4--5 days, and then immersed into 20% sucrose and 2% polyvinylpyrrolidone (PVP) at 4°C overnight. Then sample was embedded into 8% gelatin in 20% sucrose and 2% PVP embedding medium. Samples were sectioned at 50 µm in thickness. Sections were incubated with goat anti-LepR (R and D system, AF497), rabbit anti-Laminin (Sigma, L9393), rat anti-CD45 (Biolegend, 103101), rat anti-Endomucin (Santa cruz, sc-65495), rabbit anti-Osterix (Abcam, ab22552), rabbit anti-Perilipin (Cell signaling, 9349), rat anti-mouse PDGFRβ (Biolegend, 136002), rabbit anti-mouse connexin 43 (Cell signaling, 3512) at 4°C overnight followed by Alexa Fluor 488-conjugated donkey anti-goat (Abcam, ab150129), Alexa Fluor 647 anti-rat (Abcam, ab150155) or anti-rabbit (Abcam, ab150157) secondary antibodies incubation 1 hr at RT. For lipid staining, BODIPY dye (ThermoFisher scientific, D3822) was added together with secondary antibody and incubate for 1 hr at RT. For EdU staining, mice received 1.6 mg/kg EdU 1 day and 3 hr before sacrifice and the staining was carried out according to the manufacturer's instructions (ThermoFisher scientific, Click-iT EdU Alexa Fluor 647 Imaging Kit, D3822). To characterize bone marrow vessels after DT injections, all vessels in a 0.3 mm^2^ area in the diaphyseal bone marrow were selected to measure their diameter of semi-minor axis (vessel diameter), area (vessel area), and number (vessel density).

To reconstruct 3D structure of bone marrow, fluorescence images were captured by a Zeiss LSM 710 scanning confocal microscope interfaced with the Zen 2012 software (Carl Zeiss Microimaging LLC, Thornwood, NY). Confocal image stacks were collected to a depth of \~50 µm and a step size of 1 µm at 63x magnification. Laser power and detector sensitivity were adjusted for z-correction to compensate for signal dissipation at greater imaging depths. Detector gain and offset were adjusted according to the most intense regions to ensure minimal saturation of the signal over the entire imaging area. Imaris 9.2 software (Oxford instruments, Switzerland) was used for processing z-stack and generating movies. The number of cell processes per cell was manually quantified.

Cell culture {#s4-6}
------------

For CFU-F assay, unsorted endosteal bone marrow cells were plated at 1 × 10^6^ cells/T25 flask. Sorted endosteal bone marrow cells were plated at 1 × 10^4^, 1 × 10^4^, and 9.8 × 10^5^ cells/T25 flask for top 1%, 1--2%, and \>2% group, respectively, based on Td intensity. Cells were cultured in growth medium (α-MEM supplemented with 15% FBS, 0.1% β-mercaptoethanol, 20 mM glutamine, 100 IU/ml penicillin, and 100 µg/ml streptomycin) for 7 days before counting CFU-F number.

Mesenchymal progenitors were obtained by culturing endosteal bone marrow cells at a high density (3 × 10^6^ cells/T25 flask). Once confluent, cells were cultured in adipogenic medium (DMEM with 10% FBS, 10 ng/ml triiodothyronine, 1 µM rosiglitazone, 1 µM dexamethasone, 10 µg/ml insulin, 100 IU/ml penicillin, and 100 µg/ml streptomycin) for 7 days. Brightfield and fluorescent images of mesenchymal progenitors from 1-month-old Adipoq:Td mice undergoing adipogenic differentiation were taken from day 0 to 5 by fluorescence inverted microscopy (Nikon Eclipse, TE2000-U).

For tube formation assay, we used Endothelial Progenitor Outgrowth Cells (EPOC, Biochain, Z7030001) cultured in growth medium (mouse EPOC basal medium with 10% FBS, 100 IU/ml penicillin, and 100 µg/ml streptomycin). 3.5 × 10^5^ EPOC cells were mixed with 1.4 × 10^5^ freshly sorted Td^+^ cells from endosteal bone marrow of 1-month-old Adipoq:Td mice and seeded into matrigel-coated slide chamber. After 8 hr, cells were observed under fluorescence microscopy.

Flow cytometry {#s4-7}
--------------

Freshly isolated endosteal bone marrow cells were centrifuged to pellet cells. ACK lysing buffer (ThermoFisher Scientific, A1049201) was added to lyse red blood cells and then stained with Endomucin (FITC rat anti-mouse Endomucin, Santa cruz biotechology sc-65495) and CD31 (APC rat anti-mouse CD31, Biolegend, 561814) antibodies for 45 min on ice. After washed with flow buffer (2% FBS in PBS) twice, samples were run on LSR A and data were analyzed by FlowJo X. qRT-PCR analysis.

Sorted cells or cultured cells were collected in TRIzol Reagent (Sigma, St. Louis, MO, USA). A High-Capacity cDNAReverse Transcription Kit (Applied BioSystems, Inc, Foster City, CA, USA) was used to reverse transcribe mRNA into cDNA. Following this, quantitative realtime PCR (qRT-PCR) was performed using a Power SYBR Green PCR Master Mix Kit (Applied BioSystems, Inc). The primer sequences for the genes used in this study are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Micro-computed tomography (microCT) analysis {#s4-8}
--------------------------------------------

MicroCT analysis (microCT 35, Scanco Medical AG, Brüttisellen, Switzerland) was performed at 6 µm isotropic voxel size as described previously ([@bib7]). At the femoral midshaft, a total of 100 slices located 4.8--5.4 mm away from the distal growth plate were acquired for trabecular bone and cortical bone analyses by visually drawing the volume of interest (VOI) separately. In the L4/L5 vertebrae, the region (total about 300 slices) 50 slices away from the top and bottom end plates was acquired for trabecular bone analysis. The trabecular bone tissue within the VOI was segmented from soft tissue using a threshold of 487.0 mgHA/cm^3^ and a Gaussian noise filter (sigma = 1.2, support = 2.0). The cortical bone tissue was using a threshold of 661.6 mgHA/cm^3^ and a Gaussian noise filter (sigma = 1.2, support = 2.0). Three-dimensional standard microstructural analysis was performed to determine the geometric trabecular bone volume/total volume (BV/TV) fraction, connectivity density (Conn-Dens), trabecular thickness (Tb.Th), trabecular separation (Tb.Sp), trabecular number (Tb.N), and structure model index (SMI). For analysis of cortical bone, periosteal perimeter (Ps.Pm), endosteal perimeter (Ec.Pm), porosity, cortical bone area (Ct.Ar), cortical thickness (Ct.Th), polar moment of inertia (pMOI), and tissue mineral density (TMD) were recorded.

Hematopoietic phenotyping of bone marrow cells {#s4-9}
----------------------------------------------

Peripheral blood of mice was collected retro-orbitally. To analyze the peripheral blood of mice, red blood cells were first lysed and then stained for myeloid (rat anti-Gr-1 APC-Cy7, BD, 557661, rat anti-Mac-1 APC, eBioscience, 17-0112-83) or lymphoid lineages (rat anti-B220 FITC, eBioscience, 11-0452-82, hamster anti-CD3 PE-Cy7, eBioscience, 25-0031-82).

Bone marrow was flushed from femurs and cellularity was quantified with 3% acetic acid in methylene blue (STEMCELL). The lineage cell compartment of the bone marrow was analyzed by staining for myeloid and lymphoid lineages as in the peripheral blood. The HSPC compartment was analyzed by staining for Lineage (biotin-Ter-119, -Mac-1, -Gr-1, -CD4, -CD8α, -CD5, -CD19 and -B220 (eBioscience, 13-5921-85, 13-0051-85, 13-5931-86, 13-0112-86, 13-0452-86, 13-0041-86, 13-0081-86, 13-0193-86) followed by staining with streptavidin-PE-TexasRed (Invitrogen, SA1017), rat anti-cKit APC-Cy7 (eBioscience, 47-1171-82), rat anti-Sca1 PerCP-Cy5.5 (eBioscience, 45-5981-82), hamster anti-CD48 APC (eBioscience, 17-0481-82) and rat anti-CD150 PE-Cy7 (Biolegend, 115914). All flow cytometry analysis was performed on a BD LSR Fortessa flow cytometer and was analyzed on FlowJo v10.5.3 for MAC.

Statistics {#s4-10}
----------

Data are expressed as means ± standard error (SEM) and analyzed by t-tests or two-way ANOVA with a bonferroni's post-test for multiple comparisons using Prism software (GraphPad Software, San Diego, CA). For cell culture experiments, observations were repeated independently at least three times with a similar conclusion, and only data from a representative experiment are presented. Values of p\<0.05 were considered significant.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This paper elegantly uses single-cell RNA sequencing to refine our understanding of the mesenchymal components of the bone marrow. A major population of adipocyte lineage cells is found that functions to stabilize blood vessels and suppress bone formation. The findings also suggest that early multipotent progenitors may represent a much smaller fraction of the marrow than previously appreciated.

**Decision letter after peer review:**

Thank you for submitting your article \"Single cell transcriptomics identifies a unique adipose cell population that regulates bone marrow environment\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including J Gage Crump as the guest Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Clifford Rosen as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

This is an interesting study that uses single-cell RNA sequencing to dissect heterogeneity of the bone marrow mesenchyme from young to adult stages in mouse. The authors report a new pre-adipocyte-like bone marrow cell population named MERA, which they define as a downstream population of MSCs by single cell RNA-seq analysis. In the first part of the paper, they computationally redefine MSCs as Sca1^+^ cells based on large-scale stromal scRNA-seq datasets. In the second part, they report that ablation of MERAs by *Adipoq-Cre* causes disruption in marrow vasculature and an increase in bone formation. Together this study is significant in clarifying the cell types in the marrow that give rise to adipocytes and osteocytes, as well as revealing a type of stromal cell with adipocyte potential that restricts bone formation and ensures proper marrow structure. What sets this study apart from preceding single-cell RNA sequencing studies is that it provides functional validation of the computational discoveries.

While the reviewers recognize the potential significance of the study, there were major concerns that would need to be addressed before it is suitable for publication.

1\) The authors need to deposit their sequencing data in GEO. The data could be password protected and only accessible to the reviewers. Four out of six figures contain computational data. The reviewers found it difficult to assess the bioinformatic analysis without this raw data access.

2\) Use of a new acronym \"MERA\" appears unwarranted as these cells have many features of previously published CXCL12 abundant reticular cells (CAR cells). Along these lines, the Morrison group described Lepr^+^ perivascular stromal population back in 2012 (Ding et al.). In 2014 Zhou et al., again from Morison\'s group, demonstrated that Lepr^+^ cells gave rise to adipocytes and osteoblasts. In 2019 both Baryawno et al. (Figure 2C) and Tikhonova et al. (Sub Figure 4A) reported that a Lepr-high mesenchymal population expresses high levels of Adipoq, Cxcl12, Lpl, etc. Validation of previously published data using Adipoq-Cre-TdT system does not substantiate a discovery of a novel population. Furthermore, Lepr-high cells are pericytes, which by definition are cells that wrap around the endothelial cells, and maintain homeostasis of blood vessels. The authors should better relate their findings to these previous studies, and clarify if \"MERA\" cells are equivalent to CAR cells or a specific CAR cell subtype. The term \"MERA\" should be dropped unless they clearly demonstrate why this is a previously unreported population.

3\) The authors used Monocle and Slingshot to infer the ancestor of adipocytes and osteoblasts. They identified markers Sca1, Cd34, and Thy1 specific to that population. As correctly state those tools are used to infer differentiation trajectory and without convincing functional biological data MSC identification is an overstatement and should be greatly toned down. Can the authors identify Sca1+CD34+Thy1+ population by imaging? What is the location of that MSC population relative to the bone marrow? The authors should also reanalyze their datasets with UMAP-based dimensionality reduction to redefine the position of this \'MSC\' cluster as tSNE is not considered a good way to visualize inter-cluster relationships. An updated version of Seurat and Monocle has this function readily available in the package. In addition, the authors might consider avoiding the use of the term \"MSC\" to describe cells in vivo. MSC is a historical term largely used to describe in vitro cultured cells.

4\) The authors should more carefully validate the specificity of *Adipoq-CreER*. This line could accidentally mark \'MSCs\' as defined in their scRNA-seq analysis. Further, as pointed out by the authors, this line also labels subcutaneous adipocytes, which can exert non-cell autonomous effects on bone formation. The study using the same *Adipoq-Cre*; DTA \'fatless\' mice showed that circulating adiponectin and leptin released by subcutaneous adipocytes negatively regulate bone formation (Zou et al., 2019). The authors should highlight the caveats of this study better.

5\) The definition of pericytes and stromal cells of this study is not accurate. The authors use the term pericytes to refer to the entire perivascular stromal cell populations. The general consensus is that pericytes specifically refer to a subset of perivascular stromal cells surrounding small arteries, arterioles. What they refer to as pericytes in this study are reticular cells surrounding sinusoidal vessels. Pericytes and perisinusoidal reticular cells have different morphologies and functions. The authors should clarify the characteristics of *Adipoq-Cre* labeled cells in the revised manuscript.

6\) Rather than disputing the Aifantis and Scadden annotations, a suggestion would be to correlate their clusters in a more balanced way with these previous studies.

\[Editors\' note: further revisions were suggested prior to acceptance, as described below.\]

Thank you for submitting your article \"Single cell transcriptomics identifies a unique adipose cell population that regulates bone marrow environment\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including J Gage Crump as the guest Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Clifford Rosen as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Iannis Aifantis (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as *eLife* papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity and presentation.

The reviewers agree that this is a beautiful manuscript that details a number of novel computational and biological findings that fit well to a number of closely related datasets. While the majority of issues have been addressed in this revision, I ask that you address the following concerns before we can formally accept your manuscript.

1\) The reviewers all agree that use of the term MSC is problematic, especially given the lack of direct lineage data supporting the Sca1^+^ population behaving as stem cells in this study. The term \"MSC\" should be dropped and replaced by a more neutral term such as \"mesenchymal progenitor\". Perhaps \"early mesenchymal progenitor\" and \"late mesenchymal progenitor\" and stress that early/late refers to interpretation of scRNA-seq analysis rather than direct lineage tracing. Discussion of these populations as \"stem cells\" should also be removed throughout the manuscript.

2\) Some additional language highlighting similarities of MALP cells to previously reported CAR cells should be provided.

3\) The simple lineage diagram provided in the response letter ([Author response image 1](#respfig1){ref-type="fig"}) would be good to include in the main Figure 1. I would also suggest using LiLA instead of Ad to denote mature adipocytes in Figure 1 and beyond.

4\) I would show [Author response image 2](#respfig2){ref-type="fig"} in the paper -- potentially as supplementary data. This is a nice image and confirms the presence of rare Sca1^+^ cells. However, not essential to include if authors feel otherwise.

5\) Subsection "Single cell transcriptomic profiling of bone marrow mesenchymal lineage cells": better to say \"unlikely\" rather than \"very unlikely\".

6\) Should not say \"mature adipocyte-specific *Adipoq-Cre* reporter\" as data clearly suggest it labels a broader population. It would be better to introduce use of this *Cre* given the ability of Adipoq to label a broad population of stromal MALP cells. Rather than referring to previous publications saying *Adipoq-Cre* is a mature adipocyte marker, a more agnostic view should be taken as to what this *Cre* actually labels.
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Author response

> While the reviewers recognize the potential significance of the study, there were major concerns that would need to be addressed before it is suitable for publication.
>
> 1\) The authors need to deposit their sequencing data in GEO. The data could be password protected and only accessible to the reviewers. Four out of six figures contain computational data. The reviewers found it difficult to assess the bioinformatic analysis without this raw data access.

Sequencing data are now deposited in GEO. Please go to https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145477.

> 2\) Use of a new acronym \"MERA\" appears unwarranted as these cells have many features of previously published CXCL12 abundant reticular cells (CAR cells). Along these lines, the Morrison group described Lepr^+^ perivascular stromal population back in 2012 (Ding et al). In 2014 Zhou et al., again from Morison\'s group, demonstrated that Lepr^+^ cells gave rise to adipocytes and osteoblasts. In 2019 both Baryawno et al. (Figure 2C) and Tikhonova et al. (Sub Figure 4A) reported that a Lepr-high mesenchymal population expresses high levels of Adipoq, Cxcl12, Lpl, etc. Validation of previously published data using Adipoq-Cre-TdT system does not substantiate a discovery of a novel population. Furthermore, Lepr-high cells are pericytes, which by definition are cells that wrap around the endothelial cells, and maintain homeostasis of blood vessels. The authors should better relate their findings to these previous studies, and clarify if \"MERA\" cells are equivalent to CAR cells or a specific CAR cell subtype. The term \"MERA\" should be dropped unless they clearly demonstrate why this is a previously unreported population.

The concern raised by the reviewers is whether MERA is a previously unreported population. Based on our data and previous publications, we believe that MERAs are a major component of LepR^+^ and CAR cells, bearing resemblance to Adipo-CAR cells proposed in a recent publication (Baccin et al., 2020). Initial reports of LepR^+^ cells and CAR cells emphasized their stem cell/progenitor nature but ignored their heterogeneity (Omatsu et al., 2010, Zhou et al., 2014). Hence, many of their properties, such as perivascular residence and regulatory actions on hematopoiesis, were attributed to MSCs. Our study demonstrated that MERAs are neither MSCs nor progenitors with bi-lineage differentiation ability. Indeed, they are a novel adipose cell population not identified in the previous studies of LepR^+^/CAR cells. Recent studies using single cell RNA-seq confirmed that both LepR^+^ cells and CAR cells are heterogeneous, containing a large cell population with high adipocyte gene expression (Matsushita et al., 2020, Tikhonova et al., 2019). Functionally, we reported that MERAs regulate marrow vessels and bone formation as adipose cells but not as MSCs, which has never been reported for LepR^+^ cells and CAR cells.

During the Gordon Research Conference (Bones and Teeth) and ORS 2020 Annual Meeting last month, we consulted several bone and stem cell experts about the proper name for this novel cell population. We all agreed that these cells are located between mesenchymal progenitors and lipid-laden adipocytes (LiLAs) on the adipogenic differentiation route of bone marrow MSCs ([Author response image 1](#respfig1){ref-type="fig"}). One suggestion is to name them Adipoq^+^ cells. However, we strongly disagree with the idea of using a marker to name a subpopulation that can be hierarchically defined in a lineage. In the past, researchers have used markers, such as PaS, LepR, Cxcl12, Osterix etc., to refer to the cells they are interested in. However, this type of nomenclature is misleading in many circumstances. For example, Zhou et al. 2014 reported that LepR^+^ cells are mesenchymal progenitors with CFU-F forming and bi-lineage differentiation abilities. Thus, they concluded that LepR^+^ cells represent the main source of bone formed by adult bone marrow. Accordingly, Baryawno et al. 2019 interpreted their LepR^+^ cell cluster as MSC. However, our data and Tikhonova et al. 2019 data clearly show that LepR^+^ cells are heterogeneous covering a wide range from MSCs to adipocytes. According to our sequencing data, LepR is expressed at a much higher level in the adipocyte cluster than in the MSC cluster. Similarly, Cxcl12+ cells are also heterogeneous covering the entire mesenchymal lineage cells with a highest level of expression in the adipocyte cluster. In addition, marker expression is often fluid and dynamic among subpopulations. For example, sequencing data revealed that LepR expression in MSC cluster increases from a very low level in young mice to a substantially high level in aging mice (Figure 3---figure supplement 2D), which fits well with the conclusion from Zhou et al. 2014 that LepR^+^ cells marks MSCs only during the adult stage but not the adolescent stage. Now with more knowledge of mesenchymal subpopulations, we believe that the hierarchical location is a better way to name a subpopulation than markers.

Another suggestion is to name them adipoblast because of the analogy between these cells and osteoblasts. Interestingly, osteoblasts are located at a similar hierarchical location as our cells in the differentiation route: between mesenchymal progenitors and osteogenic terminally differentiated osteocytes ([Author response image 1](#respfig1){ref-type="fig"}). Also similar to our cells, osteoblasts are abundant and have important functions different than osteocytes.

![Large scale scRNA-seq identifies subpopulations of bone marrow mesenchymal lineage cells from MSCs to mature cells.](elife-54695-resp-fig1){#respfig1}

The third suggestion is to drop the function-related terms and simply name them based on their hierarchical location: marrow adipogenic lineage precursors (MALPs). We adopted this suggestion and revised our manuscript accordingly. However, we also favor "adipoblast". If the Editors/reviewers have a recommendation, we will be glad to modify our manuscript again. For now, we refer our cells as MALPs in this rebuttal letter and manuscript.

> 3\) The authors used Monocle and Slingshot to infer the ancestor of adipocytes and osteoblasts. They identified markers Sca1, Cd34, and Thy1 specific to that population. As correctly state those tools are used to infer differentiation trajectory and without convincing functional biological data MSC identification is an overstatement and should be greatly toned down. Can the authors identify Sca1+CD34+Thy1+ population by imaging? What is the location of that MSC population relative to the bone marrow? The authors should also reanalyze their datasets with UMAP-based dimensionality reduction to redefine the position of this \'MSC\' cluster as tSNE is not considered a good way to visualize inter-cluster relationships. An updated version of Seurat and Monocle has this function readily available in the package. In addition, the authors might consider avoiding the use of the term \"MSC\" to describe cells in vivo. MSC is a historical term largely used to describe in vitro cultured cells.

We thank the reviewers for these comments and agree that MSC is not the best term for cluster 1 cells. We added several sentences in the Results to explain that those cells are likely the most primitive cells of bone marrow mesenchymal lineage cells. We cannot exclude the possibility that there are more primitive cells that are not labeled by *Col2-Cre* but give rise to cluster 1 cells. But this possibility is low because Td expression starts from the mesenchymal condensation stage and Td labels all CFU-F colonies in Col2/Td mice. In the hematopoiesis field, HSC is defined that a single cell can re-constitute the entire blood system. Unfortunately, we do not have a similar assay in the bone field demonstrating that a single cell can generate an entire bone. Therefore, we are unable to biologically demonstrate the MSC nature of cluster 1 cells.

We also agree with the reviewers that MSC is a historical term for cultured cells. However, similar to HSC, MSC has been widely used in the literature to refer to in vivo stem cells. The most recent example is the LepR^+^ MSC cluster identified by scRNA-seq analysis of non-hematopoietic cells in bone marrow (Baryawno et al., 2019). For simplicity, we use MSCs, late MSCs, MBP, and LCP to name cluster 1, 2, 3, and 6, respectively, in the clustering plots. We will be glad to consider any other suggestions from Editors/reviewers about cluster names.

Based on the reviewers' suggestion, we added UMAP plots to the manuscript. Clearly, UMAP generated a similar clustering pattern and gene expression patterns as tSNE, further validating the differentiation trajectory of MSCs and the existence of novel mesenchymal subpopulations we identified by tSNE.

According to the reviewers' suggestion, we performed immunostaining of Sca1 and CD34 on 50 µm-thick Col2/Td bone sections. Td+Sca1+ or Td+CD34+ cells are rare with approximate one cell per section. They displayed a reticular stromal shape, which is different from the round shape of Td-Sca1+ or Td-CD34+ hematopoietic cells ([Author response image 2](#respfig2){ref-type="fig"}). They had a stromal location with no direct contact with vessels, so they did not appear to be pericytes. Since this manuscript focuses on MALPs not MSCs and more experiments are required to confirm their MSC nature, we do not include this piece of data in this manuscript.

![Detection of bone marrow MSCs in vivo.\
Representative images of stromal MSCs in 1-month-old Col2/Td mice. Arrows point to CD34+Td+ cells in A and Sca1+Td+ cells in B.](elife-54695-resp-fig2){#respfig2}

> 4\) The authors should more carefully validate the specificity of Adipoq-CreER. This line could accidentally mark \'MSCs\' as defined in their scRNA-seq analysis. Further, as pointed out by the authors, this line also labels subcutaneous adipocytes, which can exert non-cell autonomous effects on bone formation. The study using the same Adipoq-Cre; DTA \'fatless\' mice showed that circulating adiponectin and leptin released by subcutaneous adipocytes negatively regulate bone formation (Zou et al., 2019). The authors should highlight the caveats of this study better.

The reviewers might refer to the Adipoq expression in cluster 1 (MSC) of tSNE plot and dropplot. Adipoq expression level is very low in MSC cluster with only 1 transcript/cell detected in 83 cells out of 280 MSCs in 1 month dataset. On the contrary, its expression level is high in the adipocyte cluster with an average 17 transcripts/cell detected in all 1077 adipocytes. It is important to note that the detection threshold of lineage tracing is likely different from that of sequencing. Our lineage tracing data clearly revealed that both *Adipoq-Cre* and *CreER* do not label CFU-F forming cells and do not incorporate EdU. Thus, they do not mark MSCs at 1 month of age.

We thank the reviewers for pointing out the data from fatless mice. Zou et al. 2019 used *Adipoq-Cre* DTA mice with no fat tissue since development. In our study, we used *Adipoq-Cre* DTR mice with normal fat tissues before DT injections. To understand whether bone phenotypes observed in our cell ablation model are due to the crosstalk from peripheral fat depots, we repeated our experiments with fat transplantation to restore peripheral fat tissues. Interestingly, fat transplants did correct hyperglycemia but did not block the abnormal vessel and bone phenotypes, indicating that MALPs, but not peripheral fat depots, affect bone marrow vasculature and bone formation. These data are now added to the manuscript (Figure 7---figure supplement 3).

> 5\) The definition of pericytes and stromal cells of this study is not accurate. The authors use the term pericytes to refer to the entire perivascular stromal cell populations. The general consensus is that pericytes specifically refer to a subset of perivascular stromal cells surrounding small arteries, arterioles. What they refer to as pericytes in this study are reticular cells surrounding sinusoidal vessels. Pericytes and perisinusoidal reticular cells have different morphologies and functions. The authors should clarify the characteristics of Adipoq-Cre labeled cells in the revised manuscript.

Mural cells comprise two cell types required to stabilize vascular networks. Pericytes surround smaller caliber vessels, whereas vascular smooth muscle cells surround larger vessels. Also stated in a recent review (Armulik et al., 2011), "the currently accepted definition of a mature pericyte as a cell embedded within the vascular basement membrane (BM) came with the application of electron microscopy. As discussed below, this definition is difficult to apply in situations of active angiogenesis. Another commonly applied defining criterion is the presence in microvessels, i.e., capillaries, postcapillary venules, and terminal arterioles". Therefore, pericytes refer to cells surrounding capillaries but not large vessels such as arteries and arterioles. In bone, the vast majority of vessels are capillaries. Emcn staining we used here detects capillaries but not arteries.

In our manuscript, pericytes are specifically referred to cells attached to capillaries via cell body. As shown in Figure 5, pericytes appear as small bulges on the vessels that express basement membrane Laminin. Td+ cells in Adipoq/Td bone marrow exist as pericytes and stromal cells. The later one refers to those cells not attaching to vessels via cell body. However, many of them extend cell processes to wrap around vessels as another way of contact.

We apologize for the confusion and we revised our manuscript to better reflect our definition of pericytes and stromal cells.

> 6\) Rather than disputing the Aifantis and Scadden annotations, a suggestion would be to correlate their clusters in a more balanced way with these previous studies.

We thank the reviewers for this suggestion and we modify the Discussion accordingly.

\[Editors\' note: further revisions were suggested prior to acceptance, as described below.\]

> \[...\] The reviewers agree that this is a beautiful manuscript that details a number of novel computational and biological findings that fit well to a number of closely related datasets. While the majority of issues have been addressed in this revision, I ask that you address the following concerns before we can formally accept your manuscript.
>
> 1\) The reviewers all agree that use of the term MSC is problematic, especially given the lack of direct lineage data supporting the Sca1^+^ population behaving as stem cells in this study. The term \"MSC\" should be dropped and replaced by a more neutral term such as \"mesenchymal progenitor\". Perhaps \"early mesenchymal progenitor\" and \"late mesenchymal progenitor\" and stress that early/late refers to interpretation of scRNA-seq analysis rather than direct lineage tracing. Discussion of these populations as \"stem cells\" should also be removed throughout the manuscript.

We thank the reviewers for this suggestion. We agree that we cannot biologically demonstrate that Sca1^+^ cells are MSCs due to lack of suitable technique. Therefore, we change names for cluster 1-3 to early, intermediate, and late mesenchymal progenitor (EMP, IMP, and LMP), respectively. We only keep the term MSCs at the place where cited references use it.

> 2\) Some additional language highlighting similarities of MALP cells to previously reported CAR cells should be provided.

We add a sentence in the Discussion stating that due to their high Cxcl12 expression and reticular morphology, MALPs likely constitute a significant portion of CAR cells.

> 3\) The simple lineage diagram provided in the response letter ([Author response image 1](#respfig1){ref-type="fig"}) would be good to include in the main Figure 1. I would also suggest using LiLA instead of Ad to denote mature adipocytes in Figure 1 and beyond.

We wish not to include [Author response image 1](#respfig1){ref-type="fig"} in Figure 1 based on the following reasons. First, [Author response image 1](#respfig1){ref-type="fig"} is a simplified version of Figure 8. Adding it to Figure 1 will cause redundancy. Second, [Author response image 1](#respfig1){ref-type="fig"} contains MALP, whose name has not been defined in Figure 1 yet. Later, functional studies validate its hierarchical location and reveal its function in bone, leading to the name "MALP". In Figure 1, we use a general term Adipocyte for MALP due to their adipogenic marker expression. Figure 1 does not contain mature adipocyte LiLA because lipid-laden cells cannot be captured for single cell analysis.

> 4\) I would show [Author response image 2](#respfig2){ref-type="fig"} in the paper -- potentially as supplementary data. This is a nice image and confirms the presence of rare Sca1^+^ cells. However, not essential to include if authors feel otherwise.

We thank the reviewers for the appreciation of this figure. However, since this manuscript focuses on MALPs not Sca1^+^ cells and more experiments are required to confirm their MSC nature, we wish not to include this piece of data in this manuscript. We are currently exploring new technique to prove that they are true MSCs in vivo.

> 5\) Subsection "Single cell transcriptomic profiling of bone marrow mesenchymal lineage cells": better to say \"unlikely\" rather than \"very unlikely\".

We modified accordingly.

> 6\) Should not say \"mature adipocyte-specific Adipoq-Cre reporter\" as data clearly suggest it labels a broader population. It would be better to introduce use of this Cre given the ability of Adipoq to label a broad population of stromal MALP cells. Rather than referring to previous publications saying Adipoq-Cre is a mature adipocyte marker, a more agnostic view should be taken as to what this Cre actually labels.

We deleted the word "mature adipocyte" throughout the manuscript.
